The experiences of people with glioma and their caregivers: Living with uncertainty and long-term consequences (COBra Study)

Baddeley, E., Retzer, A., Seddon, K., Bulbeck, H., Nelson, A. ORCID: https://orcid.org/0000-0002-6075-8425, Calvert, M., Grants, R., Adams, R., Watts, C., Aiyegbusi, O.L., Rivera, S.C., Kearns, P., Dirven, L. and Byrne, A. 2022. The experiences of people with glioma and their caregivers: Living with uncertainty and long-term consequences (COBra Study). Presented at: 17th World Congress of the EAPC 2021, Online, 6-8 October 2021. Neuro-Oncology. , vol.24 (Supp.4) Oxford University Press, iv2. 10.1093/neuonc/noac200.007

Full text not available from this repository.

Abstract

AIMS Glioma, the most common primary brain tumour, has variable survival rates. Existing evidence describes detriment to quality of life from persistent symptoms/side effects, functional loss and feelings of disconnection, particularly in glioblastoma; however, there remains limited focus on the experience of longer-term survivors. This study aimed to ascertain the lived experience of people with glioma and their caregivers, part of a larger study identifying outcomes for a core outcome set for use in glioma trials (COBra study). METHOD Semi-structured interviews with UK glioma patients, or patient-caregiver dyads, analysed using Thematic Analysis. RESULTS Nineteen interviews were undertaken. Patients and caregivers described living with uncertainty long after diagnosis and treatment, including prognostic uncertainty and anxiety surrounding recurrence and worsening symptoms. Patients described an inability to plan long-term, struggling to return to normal activities, either due to progressive tumour symptoms, and/or treatment side effects. Long-term physical and psychological side effects were highly impactful; patients felt left alone to cope, with support following treatment dropping off rapidly. Patients/caregivers sought self-directed ways to cope, focusing on routine and achieving some normality. However, the physical and neurological effects of glioma and its treatment affected all aspects of daily life and social interactions, impacting on sense of wellbeing and quality of life. CONCLUSION People with glioma, and their caregivers, struggle with loss of normality and living with uncertainty long after diagnosis. They proactively engage in self-directed approaches towards mitigating these effects, but experience gaps in support after treatment finishes. Clinical follow up should target these aspects of assessment and intervention.

Item Type:	Conference or Workshop Item (Paper)
Date Type:	Publication
Status:	Published
Schools:	Medicine Marie Curie Palliative Care Research Centre (MCPCRC)
Publisher:	Oxford University Press
ISSN:	1523-5866
Last Modified:	26 Jul 2023 15:15
URI:	https://orca.cardiff.ac.uk/id/eprint/160599

Actions (repository staff only)

Edit Item